These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9713905)

  • 1. Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia.
    Kapitany T; Meszaros K; Lenzinger E; Schindler SD; Barnas C; Fuchs K; Sieghart W; Aschauer HN; Kasper S
    Schizophr Res; 1998 Jul; 32(2):101-6. PubMed ID: 9713905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
    Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML
    Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia and debrisoquine 4-hydroxylase (CYP2D6) genotype in Japanese schizophrenics.
    Ohmori O; Suzuki T; Kojima H; Shinkai T; Terao T; Mita T; Abe K
    Schizophr Res; 1998 Jul; 32(2):107-13. PubMed ID: 9713906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P-450 2D6*10 C188T polymorphism is associated with antipsychotic-induced persistent tardive dyskinesia in Chinese schizophrenic patients.
    Liou YJ; Wang YC; Bai YM; Lin CC; Yu SC; Liao DL; Lin MW; Chen JY; Lai IC
    Neuropsychobiology; 2004; 49(4):167-73. PubMed ID: 15118351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 2D6 genotyping and association with tardive dyskinesia in Chinese schizophrenic patients.
    Lam LC; Garcia-Barcelo MM; Ungvari GS; Tang WK; Lam VK; Kwong SL; Lau BS; Kwong PP; Waye MM; Chiu HF
    Pharmacopsychiatry; 2001 Nov; 34(6):238-41. PubMed ID: 11778144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics.
    Nikoloff D; Shim JC; Fairchild M; Patten N; Fijal BA; Koch WH; MacPherson A; Flockhart D; Yoon YR; Yoon JS; Kim YH; Shin JG
    Pharmacogenomics J; 2002; 2(6):400-7. PubMed ID: 12629505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal movements and tardive dyskinesia in smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6.
    Ellingrod VL; Schultz SK; Arndt S
    Pharmacotherapy; 2002 Nov; 22(11):1416-9. PubMed ID: 12432967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype.
    Jaanson P; Marandi T; Kiivet RA; Vasar V; Vään S; Svensson JO; Dahl ML
    Psychopharmacology (Berl); 2002 Jun; 162(1):67-73. PubMed ID: 12107620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Lerer B; Nimgaonkar VL; Thelma BK
    Schizophr Res; 2005 Jun; 75(1):21-6. PubMed ID: 15820320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?
    Koola MM; Tsapakis EM; Wright P; Smith S; Kerwin Rip RW; Nugent KL; Aitchison KJ
    J Psychopharmacol; 2014 Jul; 28(7):665-70. PubMed ID: 24595968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia: a meta-analysis.
    Patsopoulos NA; Ntzani EE; Zintzaras E; Ioannidis JP
    Pharmacogenet Genomics; 2005 Mar; 15(3):151-8. PubMed ID: 15861039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients.
    Andreassen OA; MacEwan T; Gulbrandsen AK; McCreadie RG; Steen VM
    Psychopharmacology (Berl); 1997 May; 131(2):174-9. PubMed ID: 9201806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver enzyme
    Lu JY; Tiwari AK; Freeman N; Zai GC; Luca V; Müller DJ; Tampakeras M; Herbert D; Emmerson H; Cheema SY; King N; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Remington G; Kennedy JL; Zai CC
    Pharmacogenomics; 2020 Oct; 21(15):1065-1072. PubMed ID: 32969762
    [No Abstract]   [Full Text] [Related]  

  • 16. Polymorphic drug metabolism in schizophrenic patients with tardive dyskinesia.
    Arthur H; Dahl ML; Siwers B; Sjöqvist F
    J Clin Psychopharmacol; 1995 Jun; 15(3):211-6. PubMed ID: 7635999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
    Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive effect of cytochrome P450 17alpha-hydroxylase and dopamine D3 receptor gene polymorphisms on abnormal involuntary movements in chronic schizophrenia.
    Segman RH; Heresco-Levy U; Yakir A; Goltser T; Strous R; Greenberg DA; Lerer B
    Biol Psychiatry; 2002 Feb; 51(3):261-3. PubMed ID: 11839369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 II D6 gene polymorphisms and the neuroleptic-induced extrapyramidal symptoms in Japanese schizophrenic patients.
    Inada T; Senoo H; Iijima Y; Yamauchi T; Yagi G
    Psychiatr Genet; 2003 Sep; 13(3):163-8. PubMed ID: 12960748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between debrisoquine 4-hydroxylase (CYP2D6) gene polymorphisms and schizophrenia.
    Jönsson EG; Dahl ML; Roh HK; Jerling M; Sedvall GC
    Psychiatr Genet; 1998; 8(1):25-8. PubMed ID: 9564684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.